| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | R03AC14 |
| UNII: | XTZ6AXU7KN |
| InChI Key | STJMRWALKKWQGH-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C12H18Cl2N2O |
| Molecular Weight | 277.2 |
| AlogP | 3.0 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 58.28 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 17.0 |
| Property Name | Value | Unit | Method |
|---|---|---|---|
| log P (octanol-water) | 2.000 | - | EST |
| Atmospheric OH Rate Constant | 8.64E-11 | cm3/molecule-sec | EST |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Adrenergic receptor
|
13 | 1300 | 16 | 570 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Glycogen Storage Disease Type II | 2 | D006009 | ClinicalTrials |
| Amyotrophic Lateral Sclerosis | 2 | D000690 | ClinicalTrials |
| Parkinson Disease | 2 | D010300 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 37148-27-9 |
| ChEBI | 174690 |
| ChEMBL | CHEMBL49080 |
| DrugBank | DB01407 |
| DrugCentral | 673 |
| EPA CompTox | DTXSID7022833 |
| FDA SRS | XTZ6AXU7KN |
| Human Metabolome Database | HMDB0015477 |
| PharmGKB | PA164745640 |
| PubChem | 2783 |
| SureChEMBL | SCHEMBL4722 |